Coronavirus Penny Stocks To Watch #4: Bellerophon
If you remember back in October of last year, we first covered Bellerophon (BLPH Stock Report) after it reported positive news. Shares ended up jumping after the company presented Phase 2b data for its INOpulse at CHEST’s 2019 annual meeting. Unfortunately, the penny stock has gone through its share of ups and downs. If you’re looking at the stock right now, its price is a bit different because of the reverse split the company conducted. SO it’s one of the other reasons we haven’t focused on this company since October. It just wasn’t in the region of penny stocks.
Needless to say, shares did manage to trade higher than where we initially reported on the company. But just like many other stocks, BLPH ripped lower over the past few weeks. But after hitting new 52-week lows (in penny stock range) on March 19, BLPH is back in focus in a big way. The company announced that the FDA granted the company emergency expanded access.
This allows the company’s iNO delivery system, INOpulse to immediately be used for treating COVID-19. Due to the sheer potential of this event, BLPH may be one of the top coronavirus penny stocks to watch right now.